Concepedia

Publication | Open Access

Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice

DOIFull Paper Access

30

Citations

31

References

2022

Year

Luis M. Pérez‐Belmonte, Jaime Sanz‐Cánovas, María Dolores García de Lucas, Michele Ricci, Beatriz Avilés, Lidia Cobos-Palacios, Miguel A. Pérez‐Velasco, Almudena López‐Sampalo, M. Rosa Bernal‐López, Sergio Jansen‐Chaparro,
Frontiers in Endocrinology

Abstract

In obese patients with type 2 diabetes and heart failure, the use of once-weekly semaglutide was safe and clinically efficacious, improving health and functional status. Nevertheless, more strong evidence on glucagon-like peptide-1 receptor agonists in heart failure is required.

References

YearCitations

Page 1